Dianthus Therapeutics, Inc. (DNTH)
86.48
-3.15
(-3.51%)
USD |
NASDAQ |
May 22, 16:00
86.41
-0.07
(-0.08%)
After-Hours: 20:00
Dianthus Therapeutics Shareholders Equity (Quarterly) : 1.201B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Kodiak Sciences, Inc. | 112.10M |
| Praxis Precision Medicines, Inc. | 1.410B |
| Erasca, Inc. | 393.53M |
| Tango Therapeutics, Inc. | 391.51M |
| Tyra Biosciences, Inc. | 387.58M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.247B |
| Total Liabilities (Quarterly) | 45.57M |
| Debt to Equity Ratio | 0.0011 |
| Current Ratio | 29.25 |
| Net Debt Paydown Yield | 0.00% |